Navigation Links
Sanofi Forms Partnership with UMass Boston with $1 Million Support of Student Success Program for STEM Education
Date:9/19/2013

can make a major contribution to sustaining and enhancing the local R&D ecosystem and supporting our collective future by ensuring a steady supply of young people with advanced training and education,” said Christopher Viehbacher, Chief Executive Officer, Sanofi. “By supporting a vibrant life sciences community, we are also laying the foundation for the research that will drive future innovations for patients.”

“Increased access to STEM education is essential to Massachusetts’ future economic competitiveness, including our strength as a global leader in the life sciences,” said Governor Deval Patrick. “I thank Sanofi and Genzyme for the generous contribution to our UMass Boston students and efforts to ensure that our state’s STEM workforce pipeline remains strong.”

The gift from Sanofi and Genzyme marks the third significant philanthropic gift this year supporting CSM student success programs. Earlier this year, San Francisco-based software giant Oracle gave $300,000 to support student success efforts in CSM, and Ralph and Janice James pledged $1 million to support student success efforts campus-wide.

With Sanofi and Genzyme’s support, CSM Dean Andrew Grosovsky plans to expand the student success program and develop new opportunities for undergraduate and graduate research.

“We couldn’t be more excited and grateful for this partnership with Sanofi and Genzyme,” said Dean Grosovsky. “CSM has experienced dramatic increases in enrollment and is a minority-majority college with large numbers of first-generation and low-income students. Since the retention and academic performance has been so strong, we are on track to greatly increase the number and diversity of STEM graduates. These graduates will be competitive for admission to graduate or professional schools, or to enter the STEM workforce.”

About UMass Boston
Recognized for its reputation for innovative research addressing complex issues, the University of Massa
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Freeslate’s Biologics Formulation System Selected by Sanofi Pasteur to Improve Efficiency of Formulation Development
2. Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security
3. U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios Novel Biologic Candidate for Pseudomonas aeruginosa
4. Sanofi Oncology and Colon Cancer Coalition Join Forces to Raise Awareness of Colorectal Cancer
5. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
6. Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
7. Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital
8. Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
9. Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet
10. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
11. PharmaVentures Client Sanofi Wins Scrip Outsourcing Deal of the Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... KY (PRWEB) March 31, 2015 ... 50 schools for online bachelor’s of criminal justice ... to connecting people to inspiring ideas and high ... an e-mail to the University. We are confident ... University.” , This is the site’s first ...
(Date:3/31/2015)... , March 31, 2015  Sonoa Health, a health ... , has developed a world-first consumer health portal, Health&, ... prescriptions, wearable devices and more. Today, the ... as its CEO, who brings to the table more ... which has included working closely with the biggest names ...
(Date:3/31/2015)... March 31, 2015  The Myeloma Crowd Research Initiative ... of ten proposals that will now be evaluated ... patient-led, scientifically validated funding initiative uncovering solutions for ... of the MCRI included preliminary vetting by the ... large number of innovative projects focusing on high-risk ...
(Date:3/31/2015)... March 31, 2015 This June 13th, ... the top U.S and International Medical Schools will come ... research on the application of stem cell therapy in ... is organized and funded by the Ocular Research ... has been convening intimate meetings of top experts in ...
Breaking Biology Technology:EKU Ranked in Top 50 Among Online Criminal Justice Degrees 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3Myeloma Crowd Research Initiative Selects 10 High-Risk Multiple Myeloma Proposals For Further Review 2Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2
... Earlier Identification of Toxicity, Efficacy for Pharmaceutical ... ... CITY, Calif., Aug. 29 Codexis, Inc., a private,biotechnology company ... licensed important intellectual property,from the California Institute of Technology for ...
... Corporation,(Nasdaq: DRRX ) announced today that James ... the NewsMakers in the Biotech Industry Investment,Conference to ... 6, 2007 at 11:30 a.m.,Eastern Time. (Logo: ... of the presentation will be available by accessing,DURECT,s ...
... Pharmion Corporation,(Nasdaq: PHRM ) today announced that ... Fast Track designation for oral Azacitidine in the,treatment ... are designed to facilitate the development and,expedite the ... treat serious or,life-threatening conditions and that demonstrate the ...
Cached Biology Technology:Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology 2Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 2Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 3Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 4Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 5Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes 6
(Date:3/20/2015)... 19, 2015 Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ... - Global Strategic Business Report" report to their offering. ... Geometry in US$ Thousands. The report provides separate comprehensive analytics ... Japan , Europe , ... Rest of World. Annual estimates and forecasts are ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are ...
(Date:3/18/2015)... Florida , March 18, 2015 ... as businesses, new revolutionary smart wallets and apps continue to ... Companies currently entrenched in the mobile payment industry in focus ... Group Holding Ltd. (NYSE: BABA ), Apple Inc. ... GOOG ) and Facebook Inc. (NASDAQ: FB ) ...
Breaking Biology News(10 mins):Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
... known as Ecstasy, can reverse the symptoms of Parkinson's ... condition, according to new research at Duke University Medical ... animals do not suggest Parkinson's disease patients should find ... with many dangerous side effects. The findings rather indicate ...
... how the immune system reacts to strains of ... healthy people, or so-called "community-acquired" infections--has shown for ... deadly and better at evading human immune defenses ... in hospitals and other health-care settings. , In ...
... further evidence that one of the oldest biological laws ... sump tank reservoirs of machines in an engineering workshop ... Microbiology. , Scientists from the Centre for Ecology & ... abundance and genetic diversity of bacteria living in oil-based ...
Cached Biology News:Amphetamines reverse Parkinson's disease symptoms in mice 2Amphetamines reverse Parkinson's disease symptoms in mice 3Amphetamines reverse Parkinson's disease symptoms in mice 4Emerging staph strains found to be increasingly deadly and deceptive 2Emerging staph strains found to be increasingly deadly and deceptive 3Applying ecological laws to bacteria 2
The Spheroplast Kit contains qualified reagents for the preparation of yeast spheroplasts. The reagents have been optimized for use with Pichia pastoris and are guaranteed to generate 70% spheroplast...
The Proteome Profiler Human Phospho-MAPK Array Kit contains 4 membranes - each spotted in duplicate with 23 different MAPK antibodies....
Mycoplasma tested...
Recombinant Human PTP1B (aa 2-321), CF...
Biology Products: